fullerene c60 has been researched along with Multiple Sclerosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bar-Shir, A; Basso, AS; Costa-Pinto, FA; Engel, Y; Frenkel, D; Gozin, M; Monsonego, A; Petrovic-Stojkovic, S; Puckett, L; Quintana, FJ; Weiner, HL | 1 |
1 other study(ies) available for fullerene c60 and Multiple Sclerosis
Article | Year |
---|---|
Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis.
Topics: Amino Acid Transport System X-AG; Animals; Astrocytes; Axons; B-Lymphocytes; CD11b Antigen; Chemokine CCL2; Chronic Disease; Disease Models, Animal; Disease Progression; Fullerenes; Glutamic Acid; Memory; Mice; Molecular Structure; Multiple Sclerosis; Oxidative Stress; T-Lymphocytes | 2008 |